Alpha-synuclein induces the unfolded protein response in Parkinson’s disease SNCA triplication iPSC-derived neurons

The recent generation of induced pluripotent stem cells (iPSCs) from a patient with Parkinson’s disease (PD) resulting from triplication of the α-synuclein (SNCA) gene locus allows unprecedented opportunities to explore its contribution to the molecular pathogenesis of PD. We used the double-nicking CRISPR/Cas9 system to conduct site-specific mutagenesis of SNCA in these cells, generating an isogenic iPSC line with normalized SNCA gene dosage. Comparative gene expression analysis of neuronal derivatives from these iPSCs revealed an ER stress phenotype, marked by induction of the IRE1α/XBP1 axis of the unfolded protein response (UPR) and culminating in terminal UPR activation. Neuropathological analysis of post-mortem brain tissue demonstrated that pIRE1α is expressed in PD brains within neurons containing elevated levels of α-synuclein or Lewy bodies. Having used this pair of isogenic iPSCs to define this phenotype, these cells can be further applied in UPR-targeted drug discovery towards the development of disease-modifying therapeutics.

Data and Resources

Additional Info

Field Value
Maintainer Email
Article Host Type publisher
Article Is Open Access true
Article License Type
Article Version Type publishedVersion
Citation Report
DOI 10.1093/hmg/ddx331
Date Last Updated 2019-01-04T07:42:08.587669
Evidence open (via free pdf)
Funder code(s) Biotechnology and Biological Sciences Research Council (); University of North Carolina (); National Institutes of Health (); Janssen Pharmaceuticals (); Wellcome Trust (WTISSF121302); European Commission ()
Journal Is Open Access false
Open Access Status bronze
Publisher URL